- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03744559
Behavioral Memory Modulation in Nicotine Addiction
April 24, 2025 updated by: Medical University of South Carolina
Targeting Foundational Memory Processes in Nicotine Addiction: A Translational Clinical Neuroscience Study of a Retrieval-Extinction Intervention to Reduce Craving and Smoking Behavior
The purpose of the study is to see if a behavioral intervention known as retrieval-extinction training (RET) might affect craving in response to nicotine cues (e.g., pictures, videos and objects) and smoking behavior in men and women who smoke cigarettes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In a recently published NIDA-funded study, the investigators found that lasting reductions in craving and smoking could be achieved with a brief behavioral intervention designed to alter memory processes underlying smoking-related nicotine addiction.
The proposed project will replicate and extend these findings by 1) increasing the dose of intervention so as to bolster the observed treatment effects, 2) employing brain imaging methods to identify patterns of brain activity uniquely associated with the intervention and potentially predictive of treatment outcome, 3) extending follow-up period to more completely document the long-term effects of the intervention.
Positive findings from this study could lead to the development of brief therapy that will not only improve treatment outcomes for smokers, but also be used in the treatment other substance use disorders and frequently co-occurring comorbidities such as PTSD.
Study Type
Interventional
Enrollment (Actual)
191
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria
- Healthy men and women, ages 25 to 65, who have smoked at least 10 cigarettes per day for at least 3 years.
- Participants must live within a 50-mile radius of the research facility and have reliable transportation.
- Participants must be willing to abstain from smoking starting the night before the baseline visit, and starting the night before visit 1 and remain abstinent for four consecutive days.
- Participants must agree to forego any other medication or behavioral treatment for smoking cessation while enrolled in the study (with the exception of the SC Quitline).
Exclusion Criteria
- Participants who are dependent on substances other than nicotine.
- Women who are pregnant during the clinical assessment session or either of the fMRI sessions. These participants must agree to notify the study staff if they become pregnant during the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: R-E (Retrieval Extinction)
83 anticipated participants will undergo 3 sessions on consecutive days of the Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' smoking-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of smoking-related cues (e.g., pictures).
Participants will also receive a lab-based smoking-related cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
|
Retrieval extinction training (RET) is a behavioral intervention that involves cue-elicited retrieval followed by extinction training (i.e., massed unreinforced exposure to drug-associated cues).
The first element of RET involves briefly presenting drug-associated cues to retrieve drug use memories.
The second element, occurring after a brief interval, involves extinction training.
It is argued that the initial retrieval of the memories prior to extinction training initiates a period of instability, which is followed by reconsolidation of the memories back into long-term storage.
Extinction training during the period of instability is presumed to overwrite the original drug-associated cue with a non-drug-associated cue, to attenuate expression of drug-seeking behavior.
|
|
Other: NR-E (No R-E)
83 anticipated participants will undergo 3 sessions on consecutive days of the control Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' non-smoking or neutral-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of non-smoking or neutral cues (e.g., pictures).
Participants will also receive a lab-based non-smoking or neutral cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
|
The control retrieval extinction training (RET) for the NR-E arms serves as the control intervention to the RET behavioral intervention.
The first element of the control RET involves briefly presenting retrieval cues that contain neutral, non-smoking content.
The second element, occurring after a brief interval, involves extinction training.
Based on findings from the previous NIDA-funded R21, the R-E arm reported a significant 25 percent reduction in cigarettes smoked per day during the follow-up period versus the control NR-E arm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Craving Questionnaire Score, Response to the Novel Cue
Time Frame: up to 24 weeks, Baseline, 24 hours, Weeks 2, 4, 6, 8, 12, and 24
|
At each visit (baseline, intervention sessions, and follow-up test sessions), participants will complete a Craving Questionnaire survey at multiple timepoints during each visit (baseline, and after each cue exposure).
The craving questionnaire is the average of four statements about craving for cigarettes (e.g., "I have an urge for a cigarette"), and the participants rate how they agree with the statements at that moment on a scale of 1 to 5 (1 = strongly disagree and 5 = strongly agree).
This measure will examine the behavioral response to the novel cue over the course of the study, and differences in response between the R-E arms and NR-E arms.
|
up to 24 weeks, Baseline, 24 hours, Weeks 2, 4, 6, 8, 12, and 24
|
|
Mean Cigarettes Smoked Per Day
Time Frame: up to 26 weeks, Baseline, Weeks 2, 4, 6, 8, 12, 16, 21 and 26
|
Cigarettes Smoked per Day were recorded daily and summarized at follow-up visits
|
up to 26 weeks, Baseline, Weeks 2, 4, 6, 8, 12, 16, 21 and 26
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Smoking Days
Time Frame: up to 26 weeks, Baseline, Weeks 2, 4, 6, 8, 12, 16, 21 and 26
|
Cigarettes Smoking days were recorded daily and summarized at follow-up visits.
The percentage of days since last follow up visit where smoking is recorded is reported
|
up to 26 weeks, Baseline, Weeks 2, 4, 6, 8, 12, 16, 21 and 26
|
|
Mean Mood-Craving Response to the Novel Cue
Time Frame: up to 24 weeks, Baseline, 24 Hours, Weeks 2, 4, 6, 8, 12, and 24
|
At each visit (baseline, intervention sessions, and follow-up test sessions), participants will complete a mood craving during each visit.
The mood craving form is a single item question ranging from 0 (no craving) to 100 (greatest craving possible).
This measure will examine the behavioral response to the novel cue over the course of the study, and differences in response between the R-E arms and NR-E arms.
|
up to 24 weeks, Baseline, 24 Hours, Weeks 2, 4, 6, 8, 12, and 24
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Michael Saladin, PhD, Medical University of South Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 4, 2019
Primary Completion (Actual)
October 28, 2023
Study Completion (Actual)
November 1, 2023
Study Registration Dates
First Submitted
November 13, 2018
First Submitted That Met QC Criteria
November 13, 2018
First Posted (Actual)
November 16, 2018
Study Record Updates
Last Update Posted (Actual)
April 30, 2025
Last Update Submitted That Met QC Criteria
April 24, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00069355
- R01DA043587 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nicotine Use Disorder
-
Fred Hutchinson Cancer CenterNational Institute on Drug Abuse (NIDA)CompletedNicotine Dependence | Nicotine Use Disorder | Nicotine Vaping | Vaping | Nicotine AddictionUnited States
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
-
University of ChicagoWithdrawnNicotine Use Disorder | Nicotine AddictionUnited States
-
Medical University of South CarolinaTerminatedNicotine Dependence | Nicotine Use DisorderUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedNicotine Dependence | Nicotine Use DisorderUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Nicotine Dependence | Tobacco Dependence | Smoking, Tobacco | Nicotine Use Disorder | Nicotine Dependence, Cigarettes | Smoking, Cigarette | Nicotine Dependence Tobacco Product | Tobacco; Use, Rehabilitation | Smoking (Tobacco) Addiction and other conditionsUnited States
-
Washington University School of MedicineNational Institute on Drug Abuse (NIDA); The University of Texas Health Science... and other collaboratorsRecruitingNicotine Use Disorder | Nicotine VapingUnited States
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR)RecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use Disorder | Substance Use Disorders | Nicotine Dependence | Nicotine Use DisorderCanada
-
Hadassah Medical OrganizationUnknownSmoking | Tobacco Use Disorder | Nicotine Dependence | Nicotine Use DisorderIsrael
-
Centre for Addiction and Mental HealthCanadian Cancer Society (CCS)RecruitingSmoking Cessation | Tobacco Smoking | Substance Use Disorders | Nicotine Dependence | Nicotine Use DisorderCanada
Clinical Trials on Retrieval Extinction Training (RET)
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)WithdrawnObesity | Overweight | Craving | Eating BehaviorUnited States
-
Medical University of South CarolinaCompleted
-
Beijing Normal UniversityUnknown
-
University of Texas at AustinNational Institute of Mental Health (NIMH)CompletedSpecific PhobiaUnited States
-
Gabriel Rubio Valladolid, MDInstituto de Salud Carlos III; Hospital Universitario 12 de OctubreUnknown
-
University of Michigan Rogel Cancer CenterCompletedHead and Neck Squamous Cell CarcinomaUnited States
-
Hospital Universitario 12 de OctubreMinisterio de Sanidad, Servicios Sociales e IgualdadUnknown
-
National Taipei University of Nursing and Health...Active, not recruitingAlzheimer's Disease (AD)Taiwan
-
University of ArkansasCompletedAlzheimer DiseaseUnited States
-
National Institute on Drug Abuse (NIDA)CompletedAlcohol Drinking | Alcohol Drinking Related ProblemsUnited States